Efficacy and morbidity of daunomycin (NSC-82151) added to vincristine (NSC-67574) and prednisone (NSC-10023) for remission induction of childhood acute lymphocytic leukemia.
D000380:Agranulocytosis / Q000209:etiology; D002648:Child; D003630:Daunorubicin / Q000627:therapeutic use*; D006801:Humans; D007945:Leukemia, Lymphoid / Q000150:complications / Q000188:drug therapy*; D007970:Leukopenia / Q000209:etiology; D011241:Prednisone / Q000627:therapeutic use*; D013921:Thrombocytopenia / Q000209:etiology; D014750:Vincristine / Q000627:therapeutic use*
D014750:Vincristine; D011241:Prednisone; D003630:Daunorubicin